Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors

被引:47
作者
Martin-Chouly, CAE
Astier, A
Jacob, C
Pruniaux, MP
Bertrand, C
Lagente, V
机构
[1] Univ Rennes 1, INSERM, U456, F-35043 Rennes, France
[2] Pfizer Global Res & Dev, Fresnes Labs, F-94260 Fresnes, France
关键词
metalloproteinases; PDE4; inhibitors; human lung fibroblasts;
D O I
10.1016/j.lfs.2004.01.021
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Over-expression of matrix metalloproteinases by lung fibroblasts has been blamed for much of the tissue destruction associated with airway inflammation. Because cyclic AMP is known to regulate fibroblast proliferation, as well as cytokine and extracellular matrix protein production, the current study was designed to evaluate the ability of three selective phosphodiesterase (PDE) type 4 inhibitors, rolipram, cilomilast and CI-1044, to inhibit extracellular matrix degradation. Using zymography and ELISA, we found that pro-MMP-2 release was enhanced following 24 h treatment of human lung fibroblast (MRC-5) with TGF-beta1 (10 ng/ml) or TNF-alpha (10 ng/ml), whereas PMA (0.02 muM) had no effect. One hour of pre-incubation with PDE4 inhibitors (10 muM) induced an inhibition of TNF-alpha-stimulated pro-MMP-2 release. Zymography and immunoblotting revealed that fibroblasts cultured with PMA or TNF-a released increased amounts of pro-MMP-1, whereas TGF-beta1 had no effect. Incubation with CI-1044 or cilomilast significantly prevented the TNF-alpha increase in pro-MMP-1. These results suggest that PDE4 inhibitors are effective in inhibiting the pro-MMP-2 and pro-MMP-1 secretion induced by TNF-alpha and might underline a potential therapeutic benefit of selective PDE4 inhibitors in lung diseases associated with abnormal tissue remodelling. 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:823 / 840
页数:18
相关论文
共 50 条
  • [41] Expression and Characterization of Membrane-Type 4 Matrix Metalloproteinase (MT4-MMP) and its Different Forms in Melanoma
    Hieronimus, Bettina
    Pfohl, Julian
    Busch, Christian
    Graeve, Lutz
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (01) : 198 - 210
  • [42] Identification of potential type 4 cAMP phosphodiesterase inhibitors via 3D pharmacophore modeling, virtual screening, DFT and structural bioisostere design
    Gogoi, Dhrubajyoti
    Chaliha, Amrita K.
    Sarma, Diganta
    Kakoti, Bibhuti B.
    Buragohain, Alak K.
    MEDICINAL CHEMISTRY RESEARCH, 2017, 26 (11) : 3000 - 3014
  • [43] Expression pattern analysis and activity determination of matrix metalloproteinase derived from human macrophage subsets
    Roch, Toralf
    Akymenko, Oksana
    Krueger, Anne
    Jung, Friedrich
    Ma, Nan
    Lendlein, Andreas
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2014, 58 (01) : 147 - 158
  • [44] INHIBITORS OF DNA-SYNTHESIS DERIVED FROM SENESCENT HUMAN-DIPLOID FIBROBLASTS
    SMITH, JR
    EXPERIMENTAL GERONTOLOGY, 1992, 27 (04) : 409 - 412
  • [45] Prenylated flavonoids as potent phosphodiesterase-4 inhibitors from Morus alba: Isolation, modification, and structure-activity relationship study
    Guo, Yan-Qiong
    Tang, Gui-Hua
    Lou, Lan-Lan
    Li, Wei
    Zhang, Bei
    Liu, Bo
    Yin, Sheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 144 : 758 - 766
  • [46] Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model
    Kumar, Ranjeet
    Kolloli, Afsal
    Singh, Pooja
    Vinnard, Christopher
    Kaplan, Gilla
    Subbian, Selvakumar
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 9
  • [47] Interleukin (IL)4 and IL-13 act on human lung fibroblasts -: Implication in asthma
    Doucet, C
    Brouty-Boyé, D
    Pottin-Clémenceau, C
    Canonica, GW
    Jasmin, C
    Azzarone, B
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (10) : 2129 - 2139
  • [48] Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition
    Oger, Stephanie
    Behr-Roussel, Delphine
    Gorny, Diane
    Denys, Pierre
    Lebret, Thierry
    Alexandre, Laurent
    Giuliano, Franqois
    EUROPEAN UROLOGY, 2007, 51 (03) : 772 - 781
  • [49] IMMUNE MODULATION OF METALLOPROTEINASE PRODUCTION IN HUMAN MACROPHAGES - SELECTIVE PRETRANSLATIONAL SUPPRESSION OF INTERSTITIAL COLLAGENASE AND STROMELYSIN BIOSYNTHESIS BY INTERFERON-GAMMA
    SHAPIRO, SD
    CAMPBELL, EJ
    KOBAYASHI, DK
    WELGUS, HG
    JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (04) : 1204 - 1210
  • [50] Do phosphodiesterase type 5 inhibitors generics enhance discontinuation due to price with patients suffering from erectile dysfunction?
    Baydaroglu, E.
    Eschwege, P.
    Hubert, J.
    El Osta, R.
    PROGRES EN UROLOGIE, 2019, 29 (06): : 326 - 331